Total Payments
$254,169
2023 Payments
$274.32
Companies
6
Transactions
243
Medicare Patients
2,210
Medicare Billing
$97,296
Payment Breakdown by Category
Other$129,943 (51.1%)
Consulting$77,303 (30.4%)
Travel$43,138 (17.0%)
Food & Beverage$3,784 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $129,943 | 44 | 51.1% |
| Consulting Fee | $77,303 | 30 | 30.4% |
| Travel and Lodging | $43,138 | 125 | 17.0% |
| Food and Beverage | $3,784 | 44 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $79,660 | 101 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $50,663 | 42 | $0 (2019) |
| Abbott Laboratories | $45,899 | 46 | $0 (2023) |
| Otsuka Pharmaceutical Co., Ltd. | $42,119 | 41 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $35,779 | 12 | $0 (2022) |
| Nuwellis, Inc. | $49.12 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $274.32 | 2 | Abbott Laboratories ($274.32) |
| 2022 | $7,595 | 4 | Otsuka Pharmaceutical Co., Ltd. ($4,200) |
| 2021 | $8,479 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($6,230) |
| 2020 | $12,410 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($12,410) |
| 2019 | $34,026 | 19 | Novartis Pharmaceuticals Corporation ($14,697) |
| 2018 | $67,239 | 78 | Otsuka Pharmaceutical Co., Ltd. ($22,314) |
| 2017 | $124,145 | 134 | Otsuka America Pharmaceutical, Inc. ($64,762) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $146.32 | General |
| Category: Heart Failure | ||||||
| 03/27/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $128.00 | General |
| Category: Heart Failure | ||||||
| 10/25/2022 | Otsuka Pharmaceutical Co., Ltd. | SAMSCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $970.00 | General |
| 03/25/2022 | Otsuka Pharmaceutical Co., Ltd. | SAMSCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: NEPHROLOGY | ||||||
| 01/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $2,425.00 | General |
| 12/17/2021 | Nuwellis, Inc. | AQUADEX SMARTFLOW CONSOLE (Device) | Food and Beverage | Cash or cash equivalent | $49.12 | General |
| Category: Cardiology | ||||||
| 10/25/2021 | Otsuka Pharmaceutical Co., Ltd. | SAMSCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: CARDIOLOGY | ||||||
| 09/29/2021 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $5,280.00 | General |
| 04/01/2021 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 07/20/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $6,650.00 | General |
| 01/14/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $5,760.00 | General |
| 11/06/2019 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered (Drug) | Travel and Lodging | In-kind items and services | $603.51 | General |
| 10/22/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,246.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Travel and Lodging | Cash or cash equivalent | $873.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2019 | Otsuka Pharmaceutical Co., Ltd. | SAMSCA (Drug) | Travel and Lodging | In-kind items and services | $3,212.38 | General |
| Category: NEPHROLOGY | ||||||
| 09/06/2019 | Otsuka Pharmaceutical Co., Ltd. | SAMSCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,000.00 | General |
| Category: NEPHROLOGY | ||||||
| 09/04/2019 | Otsuka Pharmaceutical Co., Ltd. | SAMSCA (Drug) | Travel and Lodging | In-kind items and services | $3,193.01 | General |
| Category: NEPHROLOGY | ||||||
| 08/12/2019 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered (Drug) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 06/24/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,705.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/24/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Travel and Lodging | Cash or cash equivalent | $679.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/24/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $65.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,246.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Travel and Lodging | Cash or cash equivalent | $897.80 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 420 | 499 | $82,950 | $16,896 |
| 2022 | 8 | 530 | 646 | $85,484 | $18,293 |
| 2021 | 11 | 694 | 882 | $133,725 | $31,639 |
| 2020 | 11 | 566 | 696 | $124,123 | $30,468 |
Total Patients
2,210
Total Services
2,723
Medicare Billing
$97,296
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 56 | 60 | $18,660 | $3,769 | 20.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 64 | 65 | $21,385 | $3,119 | 14.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 42 | $10,416 | $2,470 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 24 | $8,520 | $2,229 | 26.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $8,388 | $1,821 | 21.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 189 | 242 | $6,292 | $1,433 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $5,941 | $1,242 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $2,112 | $514.70 | 24.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 12 | 12 | $924.00 | $244.80 | 26.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 12 | 12 | $312.00 | $52.60 | 16.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 86 | 87 | $27,231 | $4,510 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 55 | 62 | $18,352 | $4,180 | 22.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 281 | 363 | $9,075 | $2,263 | 24.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 28 | $9,464 | $2,244 | 23.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 38 | $8,968 | $2,120 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $8,265 | $2,002 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 12 | $2,196 | $499.29 | 22.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2022 | 21 | 21 | $1,533 | $386.24 | 25.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 15 | 16 | $400.00 | $88.19 | 22.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 93 | 95 | $28,310 | $5,103 | 18.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 63 | 73 | $20,586 | $5,025 | 24.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 46 | $14,812 | $3,751 | 25.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 19 | $13,414 | $3,273 | 24.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 372 | 488 | $11,712 | $3,060 | 26.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 25 | 29 | $11,310 | $2,969 | 26.2% |
About Dr. Steven Goldsmith, MD
Dr. Steven Goldsmith, MD is a Cardiovascular Disease healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285673947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Goldsmith, MD has received a total of $254,169 in payments from pharmaceutical and medical device companies, with $274.32 received in 2023. These payments were reported across 243 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($129,943).
As a Medicare-enrolled provider, Goldsmith has provided services to 2,210 Medicare beneficiaries, totaling 2,723 services with total Medicare billing of $97,296. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Minneapolis, MN
- Active Since 06/06/2006
- Last Updated 10/02/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1285673947
Products in Payments
- SAMSCA (Drug) $121,779
- ENTRESTO (Drug) $50,663
- CardioMEMS HF System (Device) $45,625
- Non-Covered $28,480
- Non-Covered (Drug) $3,904
- CARDIOMEMS (Device) $274.32
- AQUADEX SMARTFLOW CONSOLE (Device) $49.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Minneapolis
Dr. Jeffrey Chambers, M.d, M.D
Cardiovascular Disease — Payments: $3.1M
Cardiovascular Disease $3.1M
Dr. Markus Meyer, M.d, M.D
Cardiovascular Disease — Payments: $716,757
Cardiovascular Disease $716,757
Robert Schwartz, Md, MD
Cardiovascular Disease — Payments: $627,332
Cardiovascular Disease $627,332
Emmanouil Brilakis, Md, MD
Cardiovascular Disease — Payments: $625,583
Cardiovascular Disease $625,583
Robert Van Tassel, Md, MD
Cardiovascular Disease — Payments: $592,604
Cardiovascular Disease $592,604
Dr. Inderjit Anand, Md, Frcp, D Phil, Fa, MD, FRCP, D PHIL, FA
Cardiovascular Disease — Payments: $497,056
Cardiovascular Disease $497,056